Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Huarkon Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates large-scale production facilities that comply with Good Manufacturing Practice (GMP) standards, producing a variety of oral solids, injections, and topical medications. Its product portfolio spans multiple therapeutic areas, including cardiovascular health, gastroenterology, and respiratory medicine. Huarkon is recognized for its integration of traditional pharmaceutical manufacturing with modern quality control systems to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Huarkon Pharmaceutical.